{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001557746","name":"Aclaris Therapeutics, Inc.","summary":"Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel small and large molecule product candidates for immuno-inflammatory diseases. Its pipeline includes bosakitug (ATI-045), an anti-TSLP monoclonal antibody for atopic dermatitis; ATI-2138, an oral covalent ITK/JAK3 dual inhibitor; ATI-052, an anti-TSLP/anti-IL-4Ra bispecific antibody; and ATI-9494, a JAK-sparing ITK inhibitor. The company uses its proprietary KINect drug discovery platform and seeks third-party partnerships for further development and commercialization.","people":[],"products":[{"name":"Bosakitug (ATI-045)","type":"platform","description":"Investigational humanized anti-TSLP monoclonal antibody for atopic dermatitis and other immuno-inflammatory diseases, licensed from Biosion for global rights excluding Greater China."},{"name":"ATI-2138","type":"platform","description":"Investigational oral covalent dual inhibitor of ITK and JAK3 for T cell-mediated autoimmune diseases including atopic dermatitis."},{"name":"ATI-052","type":"platform","description":"Investigational humanized anti-TSLP and anti-IL-4Ra bispecific antibody for atopic, immunologic, and respiratory diseases, licensed from Biosion excluding Greater China."},{"name":"ATI-9494","type":"platform","description":"Investigational oral covalent JAK-sparing dual inhibitor of ITK and TXK with differentiated pharmacological properties."},{"name":"KINect Platform","type":"platform","description":"Proprietary drug discovery platform combining a chemical library of kinase inhibitors, structure-based drug design, and custom kinase assays to identify small molecule candidates."}],"partnerships":[{"partner_name":"Biosion, Inc.","partnership_type":"licensing","description":"Exclusive global license (excluding Greater China) for bosakitug (ATI-045) and ATI-052.","start_date":null},{"partner_name":"CTTQ","partnership_type":"licensing","description":"CTTQ licenses bosakitug from Biosion for Greater China territory and is studying it in severe asthma, chronic rhinosinusitis with nasal polyps, and COPD.","start_date":null}],"affiliations":[],"origin":{"leaf":"2b36a9224f81bb72c0d5a2ec27aa2e948a4369b592ac1ac6a7cdeb96b58f0644","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"b391c103445c8d9314cedfd990aeb40ccc53214da2e079aa57397b57a07a86ce","parent":"10d4c7a0baea719247f0a4ae9d2f0023f0831027a4119adfade32ac4ba00af8e","source":"0001104659-26-020540","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":119,"hourly_limit":500,"remaining":381,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}